Novasign
Novasign is building Novasign Studio, a hybrid-model and automation platform that accelerates development of life-saving therapies, next-generation enzymes, and sustainable food technologies. The company is rapidly scaling its SaaS product and expanding its engineering team to support growth. This role is for a mid–senior level full-stack engineer joining the core product team.
Novasign is a Vienna-based technology company founded in 2019 that develops Novasign Studio, a bioprocess modeling and digital twin software platform for biopharma, CDMOs, and industrial biotech organizations. The platform combines hybrid modeling, experimental design, data preparation, and simulation into a unified, no-code workflow environment to reduce experimental burden and accelerate process development and scale-up decisions. Novasign also offers bioprocess consulting, training, and software services to support clients across the full bioprocess development lifecycle.
Repligen Partners with Novasign to Further Advance Bioprocessing Digitalization
Aug 4, 2025
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
Jul 31, 2025
Repligen Corporation Reports Q3 2025 Financial Results
Oct 28, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novasign.
Women in Science: Are we Making Real Progress Towards Gender Equality?
Feb 11, 2025